Rosetta Genomics Ltd (ROSGQ)
0.00
USD |
OTCM |
May 03, 16:00
Rosetta Genomics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2017 | 2.178 |
| December 31, 2016 | 0.832 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0116 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | |
| December 31, 2014 | 0.00 |
| September 30, 2014 |
| Date | Value |
|---|---|
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | -0.035 |
| September 30, 2010 | 0.1253 |
| June 30, 2010 | 0.0226 |
| March 31, 2010 | 0.0146 |
| December 31, 2009 | 0.2442 |
| September 30, 2009 | 0.1471 |
| June 30, 2009 | 0.1175 |
| March 31, 2009 | 0.1205 |
| December 31, 2008 | 0.0602 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Compugen Ltd | 0.00 |
| Pluri Inc | 5.547 |
| BioLine Rx Ltd | 0.7391 |
| Can Fite Biofarma Ltd | 0.00 |
| BiomX Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.207M |
| Total Liabilities (Quarterly) | 5.108M |
| Shareholders Equity (Quarterly) | 1.099M |